• BMN 673: Rethinking PARP Sensitivity

  2026-09-18

  BMN 673, also known as Talazoparib, offers translational researchers a powerful way to study how catalytic PARP inhibition and PARP–DNA complex trapping interact with homologous recombination status, spliceosome regulation, and pathway context. This article connects recent hepatocellular carcinoma findings involving SmD2 with practical assay design, model selection, and biomarker strategy.

• HyperFluor 488 Goat Anti-Rabbit IgG: Practical Guide

  2026-09-18

  This guide explains how to use HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody as a fluorescent secondary antibody for rabbit primary antibodies in microscopy, immunostaining, and flow cytometry. It should not be used as a universal reagent for non-rabbit primaries, direct labeling workflows, or live-cell assays without addressing the sodium azide-containing formulation.

• Doxorubicin Hydrochloride: Assay Workflows

  2026-09-17

  Build reproducible cancer chemotherapy research workflows with Doxorubicin hydrochloride, from dose–response and apoptosis assay design to DNA-damage profiling. The same compound also supports a translational cardiotoxicity model when cardiac function, oxidative stress, and ferroptosis-linked endpoints are measured together.

• Dual-Action Inhibitors Reshape p38α Dephosphorylation

  2026-09-17

  A 2024 bioRxiv study shows that selected kinase inhibitors can do more than block p38α activity: they can also increase WIP1-mediated dephosphorylation of the activation-loop phosphothreonine. Structural data explain this effect by revealing inhibitor-stabilized activation-loop conformations that expose the phosphatase substrate site, suggesting a strategy for improving kinase inhibitor potency and specificity.

• SB203580: From p38 Inhibition to Translation

  2026-09-16

  SB203580 offers a precise way to interrogate p38 MAPK activity while exposing the experimental decisions that determine translational value. This thought-leadership analysis connects ATP-site inhibition with the FAK–p38 MAPK–GATA4 axis implicated in diabetic bladder repair, and outlines a rigorous strategy for moving from pathway observation to causal evidence.

• SP600125: JNK Inhibition Beyond the Product Page

  2026-09-16

  SP600125 is more than a pathway inhibitor: it is a practical instrument for separating JNK-dependent transcription, cytokine output, and cell fate from the broader stress-response network. This thought-leadership guide connects biochemical selectivity with translational assay design, while defining what the current evidence supports—and what remains to be tested.

• Rotigotine Assay Design: From Receptor Biology to QC

  2026-09-15

  Rotigotine is a dopamine D2/D3 receptor agonist with a broader receptor profile than a simple pathway probe. This article provides a practical framework linking receptor pharmacology, model selection, assay controls, and impurity-aware analytical quality control.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-09-15

  A 2025 study identifies activity-dependent Neuroligin 1 proteolysis in the ventral hippocampus as a mechanism that maintains, rather than merely forms, social memory. Its combination of secretase perturbation, domain-specific peptide rescue, behavioral testing, and synaptic readouts links NLG1-CTD signaling to cofilin regulation and dendritic spine remodeling.

• Anisomycin Workflows for JNK Apoptosis Research

  2026-09-14

  Build reproducible JNK activation and apoptosis assays with Anisomycin, from rapid phospho-signaling screens to delayed cell-death endpoints. The same workflow logic also helps position JNK perturbation alongside emerging synaptic-plasticity research without confusing pathway activation with proof of mechanism.

• Acetoacetic Acid Sodium Salt in Metabolic Assays

  2026-09-14

  Acetoacetic acid sodium salt is a practical model substrate for investigating ketone-body biology, fatty acid catabolism, and diabetes metabolic imbalance. This article connects chemical handling and assay interpretation with an isotope-labeling study to define stronger experimental decisions.

• Cell Cycle Assay Kit: Mechanistic DNA-Content Analysis

  2026-09-13

  Discover how the Cell Cycle Assay Kit (K2263) converts DNA content into mechanistic insight for cell cycle progression analysis, apoptosis detection, and cancer research. This guide connects PI/RNase A flow cytometry with recent findings on CGF-driven colorectal cancer stress and cell-cycle arrest.

• SB 202190: Practical p38 MAPK Workflow Guide

  2026-09-12

  Use SB 202190 as a cell-permeable p38 MAP kinase inhibitor to connect target engagement with cytokine, apoptosis, proliferation, and live-cell signaling readouts. This guide combines product-aligned dosing with single-cell ERK concepts from colorectal cancer organoid research, while emphasizing controls, timing, and troubleshooting.

• Imidazoline Antagonists and β-Cell K+ Channels

  2026-09-12

  This 1992 study showed that alinidine, antazoline, phentolamine, and tolazoline stimulate insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells, rather than through α2-adrenoceptor antagonism alone. By combining 86Rb efflux, whole-cell patch clamp, and pharmacological rescue experiments, the authors established a useful framework for separating receptor-mediated effects from direct ion-channel actions.

• Reactive Astrocytes, p38 MAPK, and Neuroinflammation

  2026-09-11

  The reference study identifies 2-chloroethanol-activated A1 reactive astrocytes as an upstream driver of M1 microglial polarization in a model of 1,2-dichloroethane-associated neuroinflammation. Its main contribution is to define astrocyte-derived IL-1β and TNF-α as potential communication signals linking chemical stress, p38 MAPK-related transcriptional responses, and microglial inflammatory activation.

• JXY and TLR4-Driven Macrophage Polarization in CAC

  2026-09-11

  Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. The study combines an orthotopic cancer model with macrophage assays, providing a mechanistic framework for interpreting immune modulation rather than treating tumor reduction as a direct cytotoxic effect.

8601 records 1/574 page Next 12345 下5页 Last page